New 'Alpha Bullets' radiation device targets tough pancreatic tumors
NCT ID NCT06698458
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new device called DaRT that delivers a special type of radiation directly into pancreatic tumors. It is being combined with standard chemotherapy in 30 people with advanced or metastatic pancreatic cancer. The main goal is to see if the combination is safe, and also to check if it helps control pain and shrink tumors.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Diffusing Alpha Radiation Emitters Therapy (DaRT) device
- What this could lead to
- If it works, this could offer a new way to control pancreatic tumors and improve survival when used with standard chemotherapy.
- What could go wrong
- This is an early safety study with only 30 participants, so results may not apply to everyone. The procedure is invasive and side effects are unknown.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Advent Health Cancer Institute
NOT_YET_RECRUITINGOrlando, Florida, 32804, United States
-
Banner MD Anderson Cancer Center
RECRUITINGGilbert, Arizona, 85234, United States
Contact Email: •••••@•••••
-
Bassett Healthcare Network
RECRUITINGCooperstown, New York, 13326, United States
-
Baylor College of Medicine
RECRUITINGHouston, Texas, 77054, United States
-
Cedars-Sinai
NOT_YET_RECRUITINGLos Angeles, California, 90048, United States
-
City of Hope
NOT_YET_RECRUITINGGoodyear, Arizona, 85338, United States
-
Emory University
RECRUITINGAtlanta, Georgia, 30308, United States
-
Hadassah Ein Kerem
RECRUITINGJerusalem, Israel
-
Honor Health
RECRUITINGScottsdale, Arizona, 85258, United States
-
Jewish General Hospital
RECRUITINGMontreal, Quebec, Canada
-
Lenox hill Hospital
NOT_YET_RECRUITINGNew York, New York, 10075, United States
-
Montefiore Medical Center
RECRUITINGThe Bronx, New York, 10467, United States
-
NYU Langone Health
RECRUITINGNew York, New York, 10016, United States
-
Texas Oncology
NOT_YET_RECRUITINGHouston, Texas, 75251, United States
-
University Cancer and Diagnostic
RECRUITINGHouston, Texas, 77089, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a vaccine help fight Hard-to-Treat cancers?
- Blood and gut clues may flag pancreatic cancer risk early
- A high-tech camera may take the guesswork out of spotting a dangerous surgery complication
- MRI might reveal hidden pancreatic risks in obesity
- Can a new PET tracer light up hidden cancers?
- Can a pill rouse the immune system against pancreatic cancer?